Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 14, 2007 Rick Aristotle Munarriz	The Fool's Look Ahead Barbies and bankers will color in the week that lies ahead. Monday: Mattel reports second-quarter earnings... Tuesday: It's Yang time at Yahoo!... etc.
The Motley Fool February 8, 2005 Tom Taulli	Retro Raider Strikes Again Carl Icahn has been very busy lately -- and his most recent prey is cardboard packaging manufacturer Temple-Inland. The stock closed unchanged yesterday at $75.75. It had surged 16% when his interest in the stock became public.
The Motley Fool November 29, 2008 Rick Aristotle Munarriz	A Fool Looks Back Dot-com weakness and bailout salvation colored in the market's clunky coloring book this past week.
The Motley Fool July 29, 2008 Rick Aristotle Munarriz	Pickens Nitpicks Yahoo! Billionaire investor Pickens is digging into the top brass at Yahoo! this week, after bailing on his investment in the Internet portal at a loss.
The Motley Fool August 5, 2008 Brian Lawler	An ImClone Deal Will Get Done Despite his tough talk, Icahn will likely complete a buyout of ImClone.
The Motley Fool June 29, 2009 Rick Aristotle Munarriz	7 Reasons Not to Worry This Week Not every company will be posting lower earnings this week. These two are expected to grow. Take a look at: Apollo Group... General Mills...
The Motley Fool June 17, 2008 Anders Bylund	Icahn, the Turncoat Who cares why he changed his position about Yahoo?'s board? Just be happy that he did.
The Motley Fool September 1, 2009 Rick Aristotle Munarriz	Icahn Handles the Truth at Yahoo! Carl Icahn has sold shares of struggling online giant Yahoo! in each of the past three trading days, enough to take his stake below 5%.
National Real Estate Investor December 4, 2002 Parke Chapman	Investor now holds 6.9% stake in Insignia Carl Icahn now holds a 6.9% stake in real estate operator Insignia Financial Group Inc.
The Motley Fool July 8, 2008 Rick Aristotle Munarriz	Doesn't Yahoo! Get a Say? Billionaire investor Carl Icahn and Microsoft insist that only a new boardroom -- ideally populated by the slate of directors that Icahn is proposing -- will lead Microsoft to reopen acquisition talks with Yahoo!.
InternetNews July 20, 2009	Icahn Pushing Again for Yahoo-Microsoft Deal Carl Icahn, the billionaire investor who made so much trouble for Yahoo last year, has spoken out in favor of a deal with Microsoft, which reportedly could be announced as early as this week.
The Motley Fool July 22, 2011 Evan Niu	Clorox to Icahn: "It's Not You, It's Me" Clorox announces that its board has unanimously rejected Icahn's unsolicited bid to acquire the company.
The Motley Fool August 20, 2010 Brian Orelli	This Billionaire Likes Biotech. Should You? It depends on how much you trust management.
The Motley Fool November 18, 2008 Brian Orelli	Icahn's Next Biotech Adventure With ImClone done, he's got his eye focused elsewhere.
The Motley Fool September 17, 2010 James Early	Today's Buy Opportunity: Johnson & Johnson The case for Johnson & Johnson is very simple: Here's a company that's been around forever, that pays a 3.5% dividend, and that's spread across arguably the most necessary sector (behind water and sewage): health care.
InternetNews November 19, 2008 David Needle	Yahoo's Critical Next Moves With Jerry Yang stepping down, will a new CEO, renewed buyout talks with Microsoft, or simply better execution help the Internet giant right itself?
InternetNews February 1, 2008 Paul Shread	Mergers, Bailouts Outweigh Job Losses, Google Microsoft's hostile bid for Yahoo carried more weight with stock traders Friday than another round of grim economic news... Motorola was another big mover... Digital River fell on its earnings report... etc.
The Motley Fool April 13, 2006 Doug Short	A Foolish Baby Shower: Johnson & Johnson If you're an advocate of these two rules -- "It's never too early to start investing" and "Invest in what you know" -- then here is an ideal pick for baby's first stock.
The Motley Fool February 4, 2010 Stephen Mauzy	My Favorite Investor I think that for most investors, the Icahn approach of buying distressed companies at very good prices even surpasses the Warren Buffett approach of buying good companies at fair prices.
The Motley Fool May 15, 2008 Rick Aristotle Munarriz	Bored of Directors at Yahoo! Carl Icahn has Yahoo!'s board in his crosshairs.
The Motley Fool June 4, 2008 Rick Aristotle Munarriz	Yahoo! Casts a Wider Net Yahoo! announces several new deals, including two with Wal-Mart and CBS, all geared toward broadening the company's advertising reach.
The Motley Fool June 24, 2009 Rick Aristotle Munarriz	5 Things That Can Go Wrong at Yahoo! Yahoo! should be very careful in its pursuit of a turnaround.
The Motley Fool January 30, 2009 Brian Orelli	Icahn's Next Target Activist investor Carl Icahn has decided to nominate a slate of five directors for the board of Amylin Pharmaceuticals, of which he owns 8.3%.
The Motley Fool July 23, 2008 Rick Aristotle Munarriz	Icahn's Spotty Track Record Carl Icahn and Yahoo! have made nice, in advance of next week's meeting, but will the peace last? Or is the current calm just the eye of the hurricane?
The Motley Fool August 1, 2008 Brian Lawler	Is $60 a Share Enough for ImClone? Bristol-Myers Squibb announced a $60-per-share offer for ImClone Systems, but are shareholders going to go for the deal?
InternetNews March 25, 2008	Citigroup: Microsoft Likely to Raise Yahoo Bid Citigroup said it is likely Microsoft will raise its $31-per-share offer for Yahoo and upgraded Yahoo shares to "buy" from "hold."
The Motley Fool May 16, 2008 Mac Greer	Fool Video: Icahn Bares His Teeth, Craig's Cyst, and 5 Stocks Approaching Greatness Can Craigslist delete eBay? Will Icahn deliver for Microsoft? These questions are discussed in this video.
The Motley Fool August 24, 2010 Matt Koppenheffer	How Much Is Johnson & Johnson Worth? Is Johnson & Johnson's stock on sale?
The Motley Fool January 29, 2008 Brian Lawler	Icahn Tries to Board USS Biogen Carl Icahn and the funds that he runs announce that they will try to get elected to three seats on the board of directors at Biogen Idec.
InternetNews February 13, 2008	Major Yahoo Investor Urges Microsoft to Raise Offer While Yahoo may have few options left, Legg Mason says Microsoft is undervaluing the company.
The Motley Fool September 15, 2008 Brian Orelli	Side Effects Don't Scare Icahn Billionaire investor Carl Icahn upped his stake in the drug company by almost 50% and now owns 7.3% of the company.
The Motley Fool December 21, 2010 Toby Shute	Chesapeake Energy in the Crosshairs What's this activist investor got planned for the energy titan?
The Motley Fool March 23, 2010 Brian Orelli	Icahn and Biogen Kiss and Make Up He gets one more seat on the board, so what's next?
The Motley Fool May 13, 2008 Brian Orelli	Omrix's Wild Ride High-growth stocks like Omrix Pharmaceutical can be hard to value. Not only are growing revenues hard to predict, but expenses can fluctuate wildly as the company grows.
The Motley Fool December 18, 2009 Rick Aristotle Munarriz	Grand Theft Icahn The activist-investor is taking an 11% stake in the struggling video-game company Take-Two Interactive.
BusinessWeek June 18, 2007 Arlene Weintraub	Johnson & Johnson's Next Baby? J&J could use an infusion of new drugs and devices from an acquisition such as Boston Scientific.
The Motley Fool October 14, 2011 Travis Hoium	Navistar International Shares Popped: What You Need to Know Shares of Navistar International drove as much as 16% higher today before dropping to a more modest gain of 8% mid-day.
Search Engine Watch June 11, 2008 Kevin Ryan	Carl Icahn Can't Save Yahoo Last week's public exchange between Icahn and Yahoo management is just the latest round of treating symptoms while ignoring the illness.
The Motley Fool May 23, 2007 Rick Aristotle Munarriz	Dumb Move, WCI If the next few quarters continue to eat away at the real estate developer's fundamentals, it's in every potential buyer's interest -- including Carl Icahn's -- to wait as long as possible. Absent a turnaround, WCI will continue to deteriorate.
The Motley Fool December 18, 2008 Selena Maranjian	Best Stock for 2009: Johnson & Johnson Johnson & Johnson is a stock that should let you sleep well at night in 2009.
The Motley Fool May 5, 2008 Rick Aristotle Munarriz	Life After Microhoo Yahoo! shareholders are resentful. Microsoft investors are relieved. The rest of the market is shocked. Is the deal really dead?
The Motley Fool May 19, 2008 Brian Orelli	What Will Icahn Do With Amylin? Carl Icahn recently took an initial position now worth around $200 million in Amylin Pharmaceuticals, and stockholders must be wondering about his motivation for the purchase.
The Motley Fool December 6, 2008 Rick Aristotle Munarriz	A Fool Looks Back Recap on last week's news: More Yahoo! buyout rumors... Detroit continues to petition its case before Congress... Johnson & Johnson buys breast implant maker Mentor... Lockheed Martin will build weather satellites...
The Motley Fool May 20, 2011 Andrea Kalvesmaki	Johnson & Johnson's Billion-Dollar Move Orthopedics are the name of the game for this company's future earnings.
The Motley Fool July 26, 2005 Rich Smith	J&J: One Pricey Stock This giant of the health-care world reported its second quarter 2005 earnings last week but, by all appearances, failed to impress Wall Street. Johnson & Johnson's become very big, very pricey.
The Motley Fool February 23, 2010 Brian Orelli	Icahn Puts His Proxy Fight Where His Money Is How patient will Carl Icahn be with Genzyme's turnaround plan? That's the $270 million question -- the value of Icahn's shares, based on his holdings at the end of the year.
The Motley Fool May 23, 2008 Rick Aristotle Munarriz	Board Games at Yahoo! Investors don't need to wait until to July to shake up the Yahoo! board. One member is stepping down now.
The Motley Fool September 24, 2008 Brian Lawler	Bristol-Myers Puts Icahn and ImClone to the Test Despite trying to project different intentions last week, pharma giant Bristol-Myers Squibb raised its bid for ImClone Systems.
The Motley Fool September 24, 2010 Anand Chokkavelu	10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list
The Motley Fool November 26, 2007 Brian Orelli	Johnson & Johnson Reorganizes -- Who Wins? Johnson & Johnson announces the second phase of its reorganization plan. While it may take years to see whether the measures will help J&J, some other companies could benefit far more quickly.